research Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
Baricitinib reduces inflammation and improves cell health in premature aging cells.
Search
for
Sort by
Research
240-270 / 470 results
research Clinical Biochemistry of Dihydrotestosterone
Understanding how DHT works is important for diagnosing and treating hormone-related disorders.
research Female Pattern Alopecia: Current Perspectives
Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.
research Direct Vasodilators and Sympatholytic Agents
Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.
research Premature Aging Syndromes: From Patients to Mechanism
Studying premature aging syndromes helps understand human aging and suggests potential treatments.
research Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center
Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.
research Possible Relationship Between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study
Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.
research Molecular Basis of Androgenetic Alopecia
research Testosterone Therapy for Women with Low Sexual Desire: A Position Statement from the Brazilian Society of Endocrinology and Metabolism
Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.
research Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells
Allopregnanolone changes gene expression in glioblastoma cells.
research Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
PRP is effective for treating hair loss, especially with other treatments.
research Association Between VEGF Gene Polymorphisms (11 Sites) and Polycystic Ovary Syndrome Risk
Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.
research Topical Medication Instillation Techniques for Glaucoma
There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.
research Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.
research Correlation Between Clinical Features, Biochemical Parameters, and Histopathological Findings in Women with Patterned Baldness: A Study from North India
Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.
research Chronic Telogen Effluvium: Is It a Distinct Condition? A Systematic Review
Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.
research Effects of the Level and Composition of Concentrate Supplements Before Breeding and in Early Gestation on Production of Different Hair Sheep Breeds
research Clinical Characteristics of Female Patterned Hair Loss in Patients Attending Hair Clinic in Thailand
Female pattern hair loss in Thailand varies by region and demographics, affecting diagnosis and treatment.
research Evaluation of Serum Ferritin, Vitamin B12, and Vitamin D Levels as Biochemical Markers of Chronic Telogen Effluvium in Women
Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.
research Retrospective Evaluation of Patients with the Diagnosis of Telogen Effluvium
Many people with hair loss had low iron and ferritin levels.
research Androgenetic Alopecia: A Review and Emerging Treatments
Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
research Androgenic Alopecia Is Associated With Higher Dietary Inflammatory Index And Lower Antioxidant Index Scores
Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.
research Critical Factors in Sample Collection and Preparation for Clinical Metabolomics of Underexplored Biological Specimens
Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.
research Telogen Effluvium Associated with Weight Loss: A Single Center Retrospective Study
Weight loss can cause temporary hair loss, especially in women and older adults.
research Acute and Chronic Telogen Effluvium
Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.
research The Association of Serum Ferritin Levels With Non-Scarring Alopecia in Women
Low iron levels are linked to hair loss in women.
research An Analytical Study of Serum Ferritin, Vitamin D, and Thyroid Function in Females with Diffuse Hair Loss
Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.
research Study of Cross-Referrals to the Dermatology Department in an Inpatient Setting at a Tertiary Care Center
Dermatology referrals improve patient care, but non-dermatologists need better training in skin conditions.
research Diffuse Hair Loss in Females
Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.
research Androgenetic Alopecia: Pathogenetic Mechanisms and Treatment Approaches
Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.